Table 2. TNM and FIGO stage with CT, MRI, and [18F]FDG-PET/CT and the change of the stage after [18F]FDG-PET/CT.
| N | CT and MRI Stage (TNM-FIGO) | ([18F]FDG-PET/CT) Stage (TNM-FIGO) | ||
|---|---|---|---|---|
| 1 | T2bN0M0 | IIB | T2bN1M0 | IIBN1 |
| 2 | T1bN1M0 | IIBN1 | T1bN1M1 | IVB |
| 3 | T2bN0M0 | IIB | T3BN0M1 | IVB |
| 4 | T3aN1M0 | IIBN1 | T3aN1M1 | IVB |
| 5 | T1bN1M0 | IIBN1 | T1bN1M1 | IVB |
| 6 | T2aN0M0 | IIA | T2aN1M1 | IVB |
| 7 | T2bN1M0 | IIBN1 | T2bN1M1 | IVB |
| 8 | T3aN1M0 | IIIAN1 | T3aN1M1 | IVB |
| 9 | T2bN1M0 | IIBN1 | T2bN1M1 | IVB |
| 10 | T1bN0M0 | IB2 | T1bN1M1 | IVB |
| 11 | pT2bpN0M0 | IIB | pT2bpN0M0 | IIB* |
| 12 | pT2apN1M0 | IIBN1 | pT2bpN1M1 | IVB |
CT: computer tomography.
MRI: magnetic resonance imaging.
[18F]FDG-PET/CT: 18F-fluorodeoxyglucose positron emission tomography integrated to computer tomography.
([18F]FDG-PET/CT) staging changed the TNM and FIGO stage in 12/66 (18.2%) patients.